Limb girdle muscular dystrophy: reappraisal of a rejected entity.
The term limb girdle muscular dystrophy (LGMD) has been introduced to delineate a distinct form of muscular dystrophy with predominantly proximal upper and lower extremity weakness. Families with evidence of both autosomal recessive and autosomal dominant modes of inheritance have been described. The recognition of other disorders presenting with weakness in a limb girdle distribution, such as the spinal muscular atrophies, dystrophinopathies, inflammatory and metabolic myopathies, casted doubt on the existence of LGMD as a separate entity. Recent linkage studies showing association between various forms of LGMD and loci on chromosome 15, 13 and 5 respectively, and the demonstration of 50K dystrophin associated glycoprotein deficiency in some cases of LGMD, strongly support the notion that limb girdle muscular dystrophy constitutes a separate group of phenotypically and genotypically distinct disorders. Further investigations are necessary to recognize the different subtypes of this disease and to identify the underlying mutations.
van der Kooi
A J
AJ
Department of Neurology, Academic Medical Center, Amsterdam, The Netherlands.
de Visser
M
M
Barth
P G
PG
D000328:Adult; D001132:Arm / Q000503:physiopathology; D002869:Chromosome Aberrations / Q000235:genetics; D025063:Chromosome Disorders; D002882:Chromosomes, Human, Pair 13; D002884:Chromosomes, Human, Pair 15; D002895:Chromosomes, Human, Pair 5; D003402:Creatine Kinase / Q000097:blood; D003937:Diagnosis, Differential; D016189:Dystrophin / Q000172:deficiency; D005838:Genotype; D006023:Glycoproteins / Q000172:deficiency; D006801:Humans; D007866:Leg / Q000503:physiopathology; D008297:Male; D018482:Muscle, Skeletal / Q000648:ultrastructure; D009136:Muscular Dystrophies / Q000175:diagnosis* / Q000235:genetics* / Q000503:physiopathology; D010641:Phenotype
D016189:Dystrophin; D006023:Glycoproteins; D003402:Creatine Kinase